What we're thankful for

Among the many things I'll be celebrating on Thanksgiving is the 10-day vacation I'm starting this afternoon. FierceBiotech, as usual, will be taking off for the day, but look for us again on Friday, when we'll publish our annual collection of the most popular stories of the year. Next week we'll be back to our regular schedule, with Executive Editor Ryan McBride steering the ship as I get the chance to prepare for the coming winter here in Vermont. Until then, happy holidays for our U.S. readers. And we promise to catch up on the rest of the world's biotech news when the FierceBiotech team starts filing stories and tweets on Monday. - John Carroll (twitter | email)

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.